About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
Year
202420232022202120202019201820162015201420132012201120102009200820072006200520042003200220012000
Edition number
№s5-17№20 (353)№19 (352)№14 (347)№18 (351)№17 (350)№15 (348)№s4-17№13 (346)№s3-17№11 (344)№12 (345)№10 (343)№КР2№9 (342)№8 (341)№КР1№7 (340)№6 (339)№5 (338)№4 (337)№s2-17№2 (335)№s1-17№3 (336)№1 (334)

№16 (349) / 2017

E.V. Biryukova
FIXED-DOSE COMBINATIONS IN THE THERAPY OF TYPE 2 DIABETES MELLITUS: THE WAY TO ACHIEVING GOOD GLYCEMIC CONTROL
6-12
M.B. Antsiferov (1), Zh.E. Belaya (2)
INCREASING THE DOSE OF SOMATOSTATIN ANALOGUES OF IN PATIENTS WITH ACTIVE FORM OF ACROMEGALY: LITERATURE REVIEW AND PROSPECTS FOR APPLICATION
13-16
A.F. Verbovoy (1), I.A. Tsanava (1), N.I. Verbovaya (1), R.A. Galkin (1), I.V. Madyanov (2)
POLYMORBIDITY AND MODERN MEDICINE
17-20
E.Yu. Komelyagina, M.B. Antsiferov
DIABETIC DISTAL POLYNEUROPATHY: THE PRINCIPLES OF DIAGNOSTICS AND THERAPY
21-25
M.B. Antsiferov
THE USE OF INSULIN GLARGINE 300 IU/ML (TOUJEO SOLOSTAR®) IN REAL CLINICAL PRACTICE
26-30
M.B. Antsiferov
EFFECT OF SGLT-2 INHIBITORS ON CARDIOVASCULAR OUTCOMES: REVIEW OF RESULTS OF CVD-REAL TRIAL
31-37
O.S. Elsukova, A.A. Sobolev
ADVANTAGES OF SWITCH TO PREMIXED INSULIN DEGLUDEC/ ASPART IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED AN OPTIMAL CONTROL WITH PREVIOUS INSULIN THERAPY
38-44
I.G. Tsvetkova (1), A.N. Kaukova (2), N.A. Belyakova (1), O.A. Vasyutkova (2), O.V. Konovalova (2), A.V. Lareva (1)
DISTURBANCES OF THE AUTONOMIC INNERVATION OF THE CARDIOVASCULAR SYSTEM AND HEMOSTASIS: THEIR ROLE IN THE CHANGE OF MICROCIRCULATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
46-50
L.N. Eliseyeva, A.Yu. Blednova, I.S. Kulabukhova, M.Sh. Khuako, M.I. Bocharnikova
EFFECTIVENESS OF ADDITIONAL CARDIOTROPIC THERAPY IN PATIENTS WITH SYMPTOMS OF HYPERTHEROSIS ON THE BACKGROUND OF DIFFUSE TOXIC GOITER
51-57
A.Yu. Chikanova (1), L.Yu. Khamnuyeva (1, 2), O.G. Karnoukhova (1), N.S. Sudakova (1), N.P. Tokareva (2)
FEATURES OF URINE MICROFLORA IN DIABETIC PATIENTS
58-61
A.F.Verbovoy, L.A. Sharonova, S.A. Burakshayev, E.V. Kotelnikova, T.V. Smirnova
OPPORTUNITIES FOR PREVENTION OF CHANGES IN SKIN AND ORAL MUCOSA IN DIABETES MELLITUS AT THE PRESENT STAGE
62-65
E.V. Biryukova (1), N.M. Platonova (2)
AMIODARONE THERAPY AND THYROID FUNCTION
66-71
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.